SMTL ID : 5o1g.1 (1 other biounit)

p53 cancer mutant Y220C in complex with compound MB487

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.35 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.83, H.86, C.145, C.149 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.83, A:H.86, A:C.145, A:C.149

1 x 9GK: 3-iodanyl-2-oxidanyl-5-(2-phenylethoxy)-4-pyrrol-1-yl-benzoic acid(Non-covalent)

9GK.2: 12 residues within 4Å: Chain A: L.52, V.54, T.57, P.58, P.60, V.64, C.127, E.128, P.129, P.130, T.137, L.164 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.52, A:T.57, A:P.60, A:P.60, A:V.64, A:T.137, A:L.164 Water bridges: A:D.135, A:D.135 Halogen bonds: A:L.52

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baud, M.G.J. et al., Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines. Eur J Med Chem (2018)

Release Date

2018-05-09

Peptides

Cellular tumor antigen p53: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cellular tumor antigen p53

Related Entries With Identical Sequence